Beta Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beta Drugs Limited has informed the stock exchange that its trading window for dealing in company securities will remain closed from 1st January 2026 until 48 hours after the announcement of its unaudited financial results for the quarter ended 31st December 2025. This restriction applies to all Directors, Officers, Designated Employees, their immediate relatives, and other persons covered under the company's insider trading code. The move is in line with SEBI's Prohibition of Insider Trading Regulations, 2015. The closure of the trading window typically signals that the company is preparing to declare its Q3 FY2026 results shortly.
This is a routine compliance filing and not directly material to stock price. It indicates that the company's December quarter results are expected soon, and insiders are barred from trading during this blackout period to prevent any unfair advantage.